FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2620348082> ?p ?o ?g. }

• W2620348082 endingPage "e6940" @default.
• W2620348082 startingPage "e6940" @default.
• W2620348082 abstract "Background: Patients undergoing hip fracture surgery frequently require blood transfusion. Tranexamic acid (TXA) has been widely used to decrease blood loss and transfusion rates in joint replacement surgery. Therefore, we conducted a meta-analysis to evaluate efficacy and safety of intravenous TXA administration in patients suffering from hip fractures. Methods: Electronic databases were searched before December 2016 by 2 independent reviewers, including Cochrane Library, EMBASE, PubMed, Web of Science, the Chinese Biomedical Literature database, and the China National Knowledge Infrastructure databases. Randomized controlled trials (RCTs) involving the efficacy and safety of intravenous (IV) TXA in patients who underwent hip surgery were included in our meta-analysis. The endpoints included total blood loss, hidden blood loss, postoperative hemoglobin decline, transfusion rates, the rate of thrombotic events, and operative time. Current meta-analysis was performed following the guidelines of the Cochrane Reviewer's Handbook and the PRISMA statement. The pooling of data was carried out using STATA V.12.0 software. Result: Eight RCTs were included, involving 598 participants. Current meta-analysis indicated that the IV TXA group had less total blood loss (weighted mean difference [WMD] = −277, 95%CI: −335 to −220, P = .000), less hidden blood loss (WMD = −246, 95%CI: −252 to −241, P = .000), lower postoperative hemoglobin decline (WMD = −1.36, 95% CI: −1.84 to −0.88, P = .000), and lower transfusion rates (risk difference [RD] = −0.19, 95% CI: −0.27 to −0.11, P = .000) compared to the control group. No significant differences were found regarding the rate of thrombotic events (RD = 0.02, 95% CI: = −0.01 to 0.05, P = .262) and operative time (WMD = −0.7, 95% CI: −3.3 to 1.9, P = .6). Conclusion: It was well established that systemic administration of TXA could reduce blood loss and transfusion rates in hip fracture surgery. But the optimal regimen, dosage, and timing still need a further research. In addition, more large and high-quality randomized controlled studies are needed to focus on the safety of IV TXA application before its wide recommendation for use in hip fracture surgery." @default.
• W2620348082 created "2017-06-05" @default.
• W2620348082 creator A5001124939 @default.
• W2620348082 creator A5001979643 @default.
• W2620348082 creator A5042996258 @default.
• W2620348082 creator A5060842906 @default.
• W2620348082 creator A5083019914 @default.
• W2620348082 creator A5087157480 @default.
• W2620348082 date "2017-05-01" @default.
• W2620348082 modified "2023-09-28" @default.
• W2620348082 title "Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis" @default.
• W2620348082 cites W1869924858 @default.
• W2620348082 cites W1877495938 @default.
• W2620348082 cites W1975379488 @default.
• W2620348082 cites W1991346186 @default.
• W2620348082 cites W1994158325 @default.
• W2620348082 cites W2004253755 @default.
• W2620348082 cites W2022691378 @default.
• W2620348082 cites W2051300945 @default.
• W2620348082 cites W2054131024 @default.
• W2620348082 cites W2070070132 @default.
• W2620348082 cites W2099970124 @default.
• W2620348082 cites W2100222319 @default.
• W2620348082 cites W2104840918 @default.
• W2620348082 cites W2125214232 @default.
• W2620348082 cites W2135405317 @default.
• W2620348082 cites W2147183994 @default.
• W2620348082 cites W2151418699 @default.
• W2620348082 cites W2178301243 @default.
• W2620348082 cites W2255020850 @default.
• W2620348082 cites W2314711013 @default.
• W2620348082 cites W2315541362 @default.
• W2620348082 cites W2400701190 @default.
• W2620348082 cites W2460522178 @default.
• W2620348082 cites W2531575551 @default.
• W2620348082 cites W2539290297 @default.
• W2620348082 cites W4238071782 @default.
• W2620348082 doi "https://doi.org/10.1097/md.0000000000006940" @default.
• W2620348082 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5457864" @default.
• W2620348082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28538384" @default.
• W2620348082 hasPublicationYear "2017" @default.
• W2620348082 type Work @default.
• W2620348082 sameAs 2620348082 @default.
• W2620348082 citedByCount "36" @default.
• W2620348082 countsByYear W26203480822018 @default.
• W2620348082 countsByYear W26203480822019 @default.
• W2620348082 countsByYear W26203480822020 @default.
• W2620348082 countsByYear W26203480822021 @default.
• W2620348082 countsByYear W26203480822022 @default.
• W2620348082 countsByYear W26203480822023 @default.
• W2620348082 crossrefType "journal-article" @default.
• W2620348082 hasAuthorship W2620348082A5001124939 @default.
• W2620348082 hasAuthorship W2620348082A5001979643 @default.
• W2620348082 hasAuthorship W2620348082A5042996258 @default.
• W2620348082 hasAuthorship W2620348082A5060842906 @default.
• W2620348082 hasAuthorship W2620348082A5083019914 @default.
• W2620348082 hasAuthorship W2620348082A5087157480 @default.
• W2620348082 hasBestOaLocation W26203480821 @default.
• W2620348082 hasConcept C126322002 @default.
• W2620348082 hasConcept C141071460 @default.
• W2620348082 hasConcept C168563851 @default.
• W2620348082 hasConcept C2776478404 @default.
• W2620348082 hasConcept C2776541429 @default.
• W2620348082 hasConcept C2778589496 @default.
• W2620348082 hasConcept C2778885795 @default.
• W2620348082 hasConcept C2779637338 @default.
• W2620348082 hasConcept C2779792907 @default.
• W2620348082 hasConcept C2780014101 @default.
• W2620348082 hasConcept C2991743468 @default.
• W2620348082 hasConcept C42219234 @default.
• W2620348082 hasConcept C71924100 @default.
• W2620348082 hasConcept C95190672 @default.
• W2620348082 hasConceptScore W2620348082C126322002 @default.
• W2620348082 hasConceptScore W2620348082C141071460 @default.
• W2620348082 hasConceptScore W2620348082C168563851 @default.
• W2620348082 hasConceptScore W2620348082C2776478404 @default.
• W2620348082 hasConceptScore W2620348082C2776541429 @default.
• W2620348082 hasConceptScore W2620348082C2778589496 @default.
• W2620348082 hasConceptScore W2620348082C2778885795 @default.
• W2620348082 hasConceptScore W2620348082C2779637338 @default.
• W2620348082 hasConceptScore W2620348082C2779792907 @default.
• W2620348082 hasConceptScore W2620348082C2780014101 @default.
• W2620348082 hasConceptScore W2620348082C2991743468 @default.
• W2620348082 hasConceptScore W2620348082C42219234 @default.
• W2620348082 hasConceptScore W2620348082C71924100 @default.
• W2620348082 hasConceptScore W2620348082C95190672 @default.
• W2620348082 hasIssue "21" @default.
• W2620348082 hasLocation W26203480821 @default.
• W2620348082 hasLocation W26203480822 @default.
• W2620348082 hasLocation W26203480823 @default.
• W2620348082 hasOpenAccess W2620348082 @default.
• W2620348082 hasPrimaryLocation W26203480821 @default.
• W2620348082 hasRelatedWork W1877495938 @default.
• W2620348082 hasRelatedWork W2149682231 @default.
• W2620348082 hasRelatedWork W2307702963 @default.
• W2620348082 hasRelatedWork W2328659429 @default.
• W2620348082 hasRelatedWork W2913640145 @default.
• W2620348082 hasRelatedWork W2939362350 @default.

• next